Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift
Moderna received full FDA approval for its COVID-19 mRNA vaccine, called SpikeVax, for use in children aged 6 months to 11 years who are considered high risk. Previously, this vaccine was only given an Emergency Use Authorization (EUA) for this age group. In May, the CDC announced a change in its COVID-19 vaccine policy, no…Continue reading Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift